# Intensive Versus Standard Treatment for Hypotension on Maternal Hemodynamics in Preeclamptic Patients

> **NCT06151444** · NA · UNKNOWN · sponsor: **General Hospital of Ningxia Medical University** · enrollment: 160 (estimated)

## Conditions studied

- Adverse Effect

## Interventions

- **DRUG:** Alpha-Agonist
- **DRUG:** α-adrenergic receptor agonist

## Key facts

- **NCT ID:** NCT06151444
- **Lead sponsor:** General Hospital of Ningxia Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-07-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2023-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06151444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06151444, "Intensive Versus Standard Treatment for Hypotension on Maternal Hemodynamics in Preeclamptic Patients". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06151444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*